Mon, Dec 11, 2023
Zydus Worldwide DMCC, a wholly-owned subsidiary, and Daewoong Pharmaceutical Co Ltd have entered into an exclusive licensing agreement to co-develop and commercialise Leuprolide Acetate for depot suspension in six dosage strengths for the US market, Zydus Lifesciences said in a regulatory filing.
Thu, Sep 21, 2023
Zydus Lifesciences share price NSE: The pharmaceutical company received final approval from the US drug regulator, the US Food and Drug Administration, for its clindamycin phosphate gel, used in the treatment of acne. Clindamycin is an antibiotic which works by stopping the growth of bacteria.
Thu, Aug 03, 2023
The approval by the US Food and Drug Administration (USFDA) is for manufacturing and marketing of Indomethacin suppositories of 50mg strength, the company said in a regulatory filing.
Thu, Jul 27, 2023
The company has received final approval from the USFDA for Plerixafor injection, which is used by patients with certain types of cancer to prepare them for stem cell transplant, Zydus Lifesciences said in a statement.
Mon, Jun 19, 2023
The approval granted by the US Food and Drug Administration (USFDA) is for Minocycline Hydrochloride extended-release tablets of strengths 55 mg, 65 mg, and 115 mg, Zydus Lifesciences said in a regulatory filing.
Fri, Jun 09, 2023
The "Phase IV EVIDENCES- XI" trial will enrol around 1,500 male and female NAFLD patients with comorbidities (either obesity, type 2 diabetes mellitus, dyslipidemia or metabolic syndrome- 200 patients each), the drug maker said in a regulatory filing.
Thu, Jun 08, 2023
Zydus Lifesciences on Thursday said it has received approval from the US health regulator to market a generic drug used to treat certain stomach and esophagus problems.
Thu, May 18, 2023
Dividend stocks: Sensex on Thursday finished the volatile session with a loss of 128.9 points or 0.2 per cent at 61,431.7, having gyrated in a range of more than 600 points in intraday trade. The Nifty 50 lost 51.8 points or 0.3 per cent for the day to settle at 18,130, after broadly moving within the 18,100-18,300 band during the session.
Zydus Lifesciences dividend 2023: Zydus Lifesciences announced a final dividend of Rs 6 per equity share of face value of Re 1 i.e., a 600 per cent payout to its shareholders.
Mon, Apr 24, 2023
Zydus Lifesciences on Monday said it has received approval from the US health regulator to market a generic medication that is used to lower triglycerides, in the American market. The company has got the final approval from USFDA to market Icosapent Ethyl Capsules in strength of 0.5 g and 1 g.
Thu, Apr 20, 2023
Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture and market its generic version of metoprolol tartrate tablets used to treat high blood pressure.
Mon, Apr 17, 2023
Isoproterenol Hydrochloride injection will be manufactured at the company's injectable manufacturing facility at Jarod, near Vadodara in India. With this, Zydus has received a total of 362 approvals and has so far filed more than 440 ANDAs since starting the filing process in FY 2003-04.
Fri, Mar 24, 2023
Doxepin hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety. It helps improve moods and feelings of well-being, relieves anxiety and tension, helps sleep better and increases the energy level, it added.
Tue, Feb 28, 2023
The drug will be manufactured at the Zydus group's formulation manufacturing facility in Moraiya, Ahmedabad. As per IQVIA MAT December 2022 data, Apixaban tablets had annual sales of USD 18,876 million in the US.
Wed, Aug 10, 2022
Tata Consumer Products Q1 results FY2023: Tata Consumer Products Ltd (TCPL) on Wednesday reported 38.2 per cent rise in consolidated net profit at Rs 276.72 crore for June quarter 2022-23
Tue, Jul 19, 2022
After two back-to-back strong closings, the Indian market opened nearly half per cent lower on Tuesday.
Tue, Jun 14, 2022
Zydus Lifesciences on Monday said its Rs 750 crore-share buyback offer will commence on June 23 and close on July 6.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.